Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Yina Diao
CONTACT
Lead
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
This is a multicenter, Phase 2 study to evaluate the safety and efficacy of Sacituzumab Tirumotecan in combination with osimertinib for neoadjuvant treatment in patients with resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
